Dr Jagoe is a respirologist and clinician-scientist. After completing his clinical training in Respirology and PhD research in nutritional aspects of lung cancer, in the UK, Dr Jagoe went on to do postdoctoral training in mechanisms of muscle wasting as a Fulbright Scholar in the laboratory of Alfred Goldberg, Harvard Medical School 1999-2002. After five years as a consultant and Clinical Senior Lecturer in Respiratory Medicine in the academic pulmonary unit at University Hospital Aintree, Liverpool, in 2007 he was recruited to McGill University in Montreal as Director of the McGill Cancer Nutrition-Rehabilitation (CNR) program. The McGill CNR is an innovative program that addresses the needs of patients with cancer cachexia. More recently in 2013 Dr Jagoe has also assumed co-directorship of the Peter Brojde Lung Cancer Centre (PBLCC) at the Jewish General Hospital in Montreal. The PBLCC integrates best oncology practice with close support from selected complementary therapists to optimize outcomes and the patient experience throughout the trajectory of lung cancer care. Dr Jagoe has received Canadian federal funding for laboratory-based research focused specifically on muscle responses to disease-related toxic stimuli including chemotherapy. In addition he remains actively involved in clinical studies to find practical solutions to improve care of patients with cancer cachexia. Most recently, as Co-PI, he has been awarded Canadian Institute for Health Research funding to initiate the Canadian arm of the MENAC trial to test the impact of multimodal therapy on nutritional and functional outcomes in lung and pancreatic cancer patients.